|
1
|
Follow-up of patients with curatively resected colorectal cancer: a practice guideline.
|
BMC Cancer
|
2003
|
2.26
|
|
2
|
Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base.
|
Can Urol Assoc J
|
2010
|
1.55
|
|
3
|
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.
|
BMC Med
|
2004
|
1.33
|
|
4
|
Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening.
|
Can J Gastroenterol
|
2012
|
1.14
|
|
5
|
The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review.
|
Can J Gastroenterol
|
2005
|
1.03
|
|
6
|
Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline.
|
BMC Cancer
|
2004
|
0.96
|
|
7
|
The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline.
|
BMC Med
|
2003
|
0.91
|
|
8
|
Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.90
|
|
9
|
Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology.
|
Arch Pathol Lab Med
|
2017
|
0.75
|
|
10
|
Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center.
|
Arch Pathol Lab Med
|
2016
|
0.75
|